All In MedTech

Device Trial Radar · NCT07178080

Comparing a New 3D Technology Used to Measure Thyroid Nodule Volume to Standard Ultrasound

Comparative Analysis of PIUR Imaging Technology for Volume Reduction Rate Measurement in Thyroid Nodule Ablations

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

75

Planned (sponsor's estimate)

Start

Sep 8, 2025

Primary completion

Sep 8, 2027

Study completion Sep 8, 2027

Sponsor

Lead sponsor
Sarasota Memorial Health Care SystemAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 17, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Crossover
Masking
Triple (participant, care provider, investigator)
Primary purpose
Basic science
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

After thyroid ablation procedure, the volume of the thyroid nodule (s) needs to be measured to see how well the procedure worked. Currently, these volumes are measured using traditional 2D ultrasound imaging. However, this approach comes with limitations because of the information 2D images cannot gather and because of differences in these measurements between different doctors. A new ultrasound technology called PIUR 3D imaging offers a novel alternative approach. The system uses advanced technology to create 3D images and can generate automated volume estimates. The PIUR imaging system, PIUR tUS Infinity, has been cleared by the Food and Drug Administration (FDA) to aid in treatment decisions when used alongside traditional 2D ultrasound imaging. The purpose of this study is to test how effective and consistent the PIUR imaging technology is compared to standard 2D ultrasound in measuring thyroid nodule volume.

Conditions

  • Thyroid Nodules
  • Thyroid Nodule

Interventions

  • PIUR tUS Infinity UltrasoundDevice

    PIUR imaging technology, cleared by the U.S. Food and Drug Administration under 510(k) (K240036), is designed to provide advanced volumetric imaging capabilities to improve accuracy in assessing nodule size and volume reduction.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Thyroid nodule volumetric measurementsTime frame: Will occur at baseline, 2 weeks, 1 month, 3 months, 6 months, and 1 year
  2. Comparison of variability between measurementsTime frame: Will occur at baseline, 2 weeks, 1 month, 3 months, 6 months, and 1 year
  3. Post-ablation thyroid volume reduction rate comparisonTime frame: 2 weeks, 1-, 3-, 6-, and 12 months.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Sarasota Memorial Health Care System

    Sarasota, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.